awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33395780-73EB71C2-3C84-4FE4-B841-C78D157D3E52
Q33395780-73EB71C2-3C84-4FE4-B841-C78D157D3E52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33395780-73EB71C2-3C84-4FE4-B841-C78D157D3E52
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients.
P2860
Q33395780-73EB71C2-3C84-4FE4-B841-C78D157D3E52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33395780-73EB71C2-3C84-4FE4-B841-C78D157D3E52
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7b74e59963cd63110ac65abf0959e16a349fd84
P2860
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa.